Illumina, Inc. (ILMN) Stock Analysis
A live, multi-source view of Illumina, Inc. (ILMN): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Illumina, Inc.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc.
Sector: Healthcare · Industry: Diagnostics & Research · United States · 8,600 employees · illumina.com
Key statistics · as of 2026-09-05
As of 2026-09-05, Illumina, Inc. (ILMN) had a market capitalization of $32.95B, a trailing P/E of 40.6 (forward 35.8) and a beta of 1.47; the shares traded in a 52-week range of $88.00 – $231.81 (122.3% over the year).
- Market cap
- $32.95B
- Enterprise value
- $34.83B
- Trailing P/E
- 40.6
- Forward P/E
- 35.8
- PEG ratio
- 2.56
- Price / book
- 11.61
- EPS (trailing)
- $5.37
- EPS (forward)
- $6.10
- Payout ratio
- 0.0%
- 52-week range
- $88.00 – $231.81
- 52-week change
- 122.3%
- Beta
- 1.47
- Average volume
- 1.9M
- Shares outstanding
- 151.0M
- Short % of float
- 10.26%
- Profit margin
- 18.3%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Illumina, Inc. (ILMN) last closed at $201.27 (the last completed close before that scan).
Technicals at the scan: RSI 46 (neutral territory), price -4.4% versus its 20-day average, 20-day versus 50-day average spread +5.3%, MACD histogram -2.28.
Sentiment inputs: 86% of recent Finnhub-scored headlines read bullish; StockTwits 100% bullish; analyst consensus score 60/100.
Next scheduled company event: in 48 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of ILMN; corporate insiders filed 0 buys and 69 sells (3 distinct filers, latest disclosure 2026-09-04). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Keith A. Meister (0B/67S), Christensen Jakob Wedel (0B/1S), Scott M. Davies (0B/1S). Who is trading what
RapidTradeView pick record
ILMN has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Illumina, Inc. (ILMN) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell ILMN.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.